提醒

Upstream Bio Inc. (UPB)

NasdaqGS: UPB · 实时价格 · USD

6.96

-0.13 (-1.83%)

收盘价： Aug 12, 2026, 1:21 PM

-1.83% (1D)

买价	5.2
市值	381.21M
营收（TTM）	3.16M
净利润（TTM）	-156.5M
贝塔值	n/a
每股收益（TTM）	-2.88
市盈率（TTM）	n/a
预期市盈率	-2.43
市净率（TTM）	1.25
市销率（TTM）	120.71
Earnings Date	Nov 4, 2026

卖价	8.84
成交量	307,332
20日均量	620,622
开盘价	7.00
前收盘价	7.09
日内区间	6.88 - 7.25
52周区间	5.85 - 33.68
分析师	n/a
目标价	39.5 (467.53%)
分红	n/a
除息日	n/a

关于 UPB

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headqu...

[阅读更多]

行业 Biotechnology

板块 Healthcare

上市日期 Oct 11, 2024

员工人数 75

交易所 NasdaqGS

股票代码 UPB

官网 https://upstreambio.com

公司完整简介

财务表现

2025年，Upstream Bio的营收为2.85M，较上一年的2.37M增长20.42%。净利润为-143.44M，增长128.39%。

财务报表

分析师预测

根据8位分析师的评级，UPB的平均评级为“null”。12个月目标价为39.5，较最新价格上涨空间467.53%。

股票预测

财报意外

新

Upstream Bio 已于 Aug 11, 2026 发布季度财报：

营收为 $1.03M 低于预期 $0, ， 82.69% 同比增长.

每股收益为 -0.73 超出预期 0.03, ， 1.35% 同比增长.

下次财报发布时间

Upstream Bio Inc. 计划于以下时间发布财报 Nov 4, 2026, 开盘前。
分析师预计营收为 ... 升级

新闻

1天前 · Zacks

Upstream Bio, Inc. (UPB) Reports Q2 Loss, Tops Revenue Estimates

Upstream Bio, Inc. (UPB) delivered earnings and revenue surprises of +6.41% and +15.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

4周前 · Zacks

Upstream Bio, Inc. (UPB) Upgraded to Buy: What Does It Mean for the Stock?

Upstream Bio, Inc. (UPB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1月前 · Insider Monkey

Is Upstream Bio, Inc. (UPB) a Rising Biotech Opportunity After New Analyst Coverage?

We recently compiled a list of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Upstream Bio, Inc. (NASDAQ:UPB) is one of the most promising stocks on our list. TheFly reported ...

1月前 · Insider Monkey

Is Upstream Bio, Inc. (UPB) the Best Low Priced Stocks to Get Rich in 2026?

Upstream Bio, Inc. (NASDAQ:UPB) is among the best low priced stocks to get rich in 2026. On June 12, JPMorgan significantly trimmed the price target on Upstream Bio, Inc. (NASDAQ:UPB) to $8 from $35, ...

3月前 · Zacks

Upstream Bio, Inc. (UPB) Reports Q1 Loss, Beats Revenue Estimates

Upstream Bio, Inc. (UPB) delivered earnings and revenue surprises of +5.96% and +102.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

第 1 页，共 2 页

Upstream Bio Inc. (UPB)